Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PG301029

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
To develop an oral formulation for PG301029, a novel potent agent for the treatment of Hepatitis C virus infection, that not only… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2008
2008
The purpose of this study was to develop and evaluate a solid nonaqueous oral dosage form for a new hepatitis C drug, PG301029… Expand
  • figure 1
  • figure 2
  • figure 3
2006
2006
The purpose of this study was to develop and evaluate a solid nonaqueous oral dosage form for a new hepatitis C drug, PG301029… Expand